Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Udenyca® Onbody™ (pegfilgrastim-cbqv) – New biosimilar approval

December 26, 2023 - Coherus announced the FDA approval of Udenyca Onbody (pegfilgrastim-cbqv), biosimilar to Neulasta® Onpro® (pegfilgrastim) kit.

Download PDF

Rx navigation